A treatment history by scopolamine session interaction ( F = 3.37 , p = 0.04 ) indicated treatment nave subjects had lower MADRS scores than treatment resistant patients ; this was significant after the second scopolamine infusion ( t = 2.15 , p = 0.03 ) .